⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform
businesswire.com
TEM
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis ® LCS Software as a Medical Device in the United States
businesswire.com
TEM
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
businesswire.com
TEM
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
prnewswire.com
SDGR
RXRX
TEM
LLY
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
businesswire.com
TEM
Tempus Announces the Launch of Paige Predict
businesswire.com
TEM
NYU Langone Health's Perlmutter Cancer Center Announces Upcoming Launch of Molecular Profiling Protocols to Monitor Cancer Treatments
prnewswire.com
TEM
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
businesswire.com
TEM
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO ® Gastrointestinal Cancers Symposium
businesswire.com
TEM
AI-Generated Digital Health Coaching Avatar Market Forecast to 2029 & 2034: Revenues to Hit $5.01 Billion by 2029
globenewswire.com
GOOGL
TEM